At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 34 enrolled
Drug / intervention
CA-008 (vocacapsaicin) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
In Brief
A Phase 2 clinical trial evaluating CA-008 (vocacapsaicin) and Placebo for Postsurgical Pain. Completed, enrolled 34 participants across 1 site.
Detailed Summary
A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostsurgical Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedMar 2021
Primary CompletionJun 2021
TodayJul 2026
First PostedMar 1, 2021
Enrollment StartSep 9, 2020
Primary CompletionJun 15, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.3 years ago
Interventions
CA-008 (vocacapsaicin)drug
Single administration of CA-008 (vocacapsaicin) versus placebo
Placebodrug
Single administration of CA-008 (vocacapsaicin) versus placebo